4 Paid Clinical Research Studies in Westwood, Kansas
Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.
Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma
To evaluate the antitumor activity and safety/tolerability of the combination (mFOLFOX + Pembrolizumab) in patients with potentially resectable adenocarcinoma of the Gastroesophage
📍 The University of Kansas Cancer Center — Westwood, Kansas
💵 * The enrolled participants will receive neoadjuvant combination of mFOLFOX every 2 weeks for 4 doses (on Days 1, 15, 29
View Study & Checklist ➔Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
This study will evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of belantamab mafodotin in combination with Velcade (bortezomib), Revlimid (lenalidomi
📍 GSK Investigational Site — Westwood, Kansas
💵 Participants will receive the combination of bortezomib, lenalidomide and dexamethasone (VRd) on a 3-week cycle until cy
View Study & Checklist ➔Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
This is a phase II, multicenter, open-label trial evaluating the safety and efficacy of pacritinib and selinexor in JAK inhibitor naïve patients with anemia and thrombocytopenia.
📍 The University of Kansas Cancer Center-Westwood — Westwood, Kansas
💵 Participants will receive pacritinib monotherapy for 1 cycle (4 weeks) and will be assessed for qualification to proceed
View Study & Checklist ➔Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
This study has two phases, Phase I and Phase II. The main goal of the Phase I portion of this research study is to see what doses post-transplant inotuzumab ozogamicin can safely b
📍 The University of Kansas Cancer Center — Westwood, Kansas
💵 Participants will receive study treatment up to 4 cycles until relapse of disease, unacceptable toxicity, or death, whic
View Study & Checklist ➔